Beauty Health (SKIN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - The Beauty Health Company (SKIN) reported a revenue of $78.2 million for the quarter ended June 2025, reflecting a year-over-year decline of 13.7% [1] - The earnings per share (EPS) was $0.03, a significant improvement from -$0.10 in the same quarter last year, indicating a positive shift in profitability [1] - The reported revenue exceeded the Zacks Consensus Estimate of $74.55 million by 4.89%, while the EPS surpassed the consensus estimate of -$0.06 by 150% [1] Revenue Breakdown - Geographic Revenue in the Americas was $52 million, slightly above the average estimate of $51.35 million, but down 9.9% year-over-year [4] - EMEA revenue reached $18.4 million, exceeding the estimated $16.23 million, but still down 4.2% compared to the previous year [4] - Asia Pacific revenue was reported at $7.7 million, significantly higher than the estimated $5.63 million, but this represented a substantial decline of 43.4% year-over-year [4] Sales Performance - Delivery Systems Net Sales amounted to $22.4 million, surpassing the average estimate of $19.43 million, but down 36.4% from the year-ago quarter [4] - Consumables Net Sales were reported at $55.8 million, slightly above the average estimate of $55.34 million, with a modest year-over-year increase of 0.7% [4] Stock Performance - Over the past month, shares of Beauty Health have declined by 23.9%, contrasting with the Zacks S&P 500 composite's increase of 1.2% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential for outperformance in the near term [3]